James R. Gruber

ETON

James R. Gruber serves as Chief Financial Officer at Eton Pharmaceuticals, Inc. (ETON). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$786.4K

Net Position

Net Seller

$786.4K

Companies Traded

ETON

Active Period

Aug 2025 – Jan 2026

3 total trades

Most Recent

Sell ETON

Jan 12, 2026 · $35.5K

James R. Gruber's Insider Trading at Eton Pharmaceuticals, Inc. (ETON)

Buys

0 · $0.00

Sells

3 · $786.4K

Total Shares Bought

Total Shares Sold

48,548

ETON Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Jan 12, 2026	Sell	2,293	$15.47	$35.5K
Dec 11, 2025	Sell	4,542	$16.99	$77.2K
Aug 19, 2025	Sell	41,713	$16.15	$673.7K

Related Insiders

Opaleye Management Inc.

10 percent owner

ETONSell · Jul 7, 2026

Jennifer McKie Adams

director

ETONSell · Jun 17, 2026

BRYNJELSEN SEAN

President & CEO

ETONSell · May 29, 2026

David Krempa

officer: Chief Business Officer

ETONSell · May 27, 2026

RIEDEL NORBERT G

Director

ETONSell · Feb 3, 2026

Ipek Erdogan-Trinkaus

Chief Commercial Officer

ETONSell · Dec 11, 2025

Explore More Insider Trading Data

ETON Insider Trading Activity

View all insider trades at Eton Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity